Cargando…

Pathologic and biologic response to preoperative endocrine therapy in patients with ER-positive ductal carcinoma in situ

BACKGROUND: Endocrine therapy is commonly recommended in the adjuvant setting for patients as treatment for ductal carcinoma in situ (DCIS). However, it is unknown whether a neoadjuvant (preoperative) anti-estrogen approach to DCIS results in any biological change. This study was undertaken to inves...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yunn-Yi, DeVries, Sandy, Anderson, Joseph, Lessing, Juan, Swain, Rebecca, Chin, Koei, Shim, Veronica, Esserman, Laura J, Waldman, Frederic M, Hwang, E Shelley
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2744704/ https://www.ncbi.nlm.nih.gov/pubmed/19689789 http://dx.doi.org/10.1186/1471-2407-9-285

Ejemplares similares

Identifying Good Candidates for Active Surveillance of Ductal Carcinoma In Situ: Insights from a Large Neoadjuvant Endocrine Therapy Cohort
por: Glencer, Alexa C., et al.
Publicado: (2022)

Identification of a robust gene signature that predicts breast cancer outcome in independent data sets
por: Korkola, James E, et al.
Publicado: (2007)

Status of Intraductal Therapy for Ductal Carcinoma in Situ
por: Flanagan, Meghan, et al.
Publicado: (2010)

Endocrine Therapy Initiation among Older Women with Ductal Carcinoma In Situ
por: Anderson, Chelsea, et al.
Publicado: (2017)

Factors predictive of invasive ductal carcinoma in cases preoperatively diagnosed as ductal carcinoma in situ
por: Takada, Koji, et al.
Publicado: (2020)

The usefulness of fluorodeoxyglucose-PET/CT for preoperative evaluation of ductal carcinoma in situ
por: Kim, Sungchul, et al.
Publicado: (2018)

An Updated Nomogram for Predicting Invasiveness in Preoperative Ductal Carcinoma In Situ of the Breast
por: Kim, Sanghwa, et al.
Publicado: (2019)

Ductal carcinoma in situ: to treat or not to treat, that is the question
por: van Seijen, Maartje, et al.
Publicado: (2019)

Neoadjuvant Endocrine Therapy and Delays in Surgery for Ductal Carcinoma in Situ: Implications for the Coronavirus Pandemic
por: Williams, Austin D., et al.
Publicado: (2021)

A clinical radiomics nomogram preoperatively to predict ductal carcinoma in situ with microinvasion in women with biopsy-confirmed ductal carcinoma in situ: a preliminary study
por: Huang, Zhou, et al.
Publicado: (2023)

The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS)
por: Hwang, E Shelley, et al.
Publicado: (2019)

Incidence and prediction of invasive disease and nodal metastasis in preoperatively diagnosed ductal carcinoma in situ
por: Osako, Tomo, et al.
Publicado: (2014)

Epidemiology, Biology, Treatment, and Prevention of Ductal Carcinoma In Situ (DCIS)
por: Punglia, Rinaa S, et al.
Publicado: (2018)

Spatial interplay of tissue hypoxia and T-cell regulation in ductal carcinoma in situ
por: Sobhani, Faranak, et al.
Publicado: (2022)

Unmasking the immune microecology of ductal carcinoma in situ with deep learning
por: Narayanan, Priya Lakshmi, et al.
Publicado: (2021)

Factors associated with upstaging in patients preoperatively diagnosed with ductal carcinoma in situ by core needle biopsy
por: Si, Jing, et al.
Publicado: (2019)

Population‐based study of the effect of preoperative breast MRI on the surgical management of ductal carcinoma in situ
por: Keymeulen, K. B. I. M., et al.
Publicado: (2019)

Axillary evaluation is not warranted in patients preoperatively diagnosed with ductal carcinoma in situ by core needle biopsy
por: Si, Jing, et al.
Publicado: (2019)

Modulation of the immune microenvironment of high-risk ductal carcinoma in situ by intralesional pembrolizumab injection
por: Glencer, Alexa C., et al.
Publicado: (2021)

ASO Visual Abstract: Neoadjuvant Endocrine Therapy and Delays in Surgery for Ductal Carcinoma in Situ: Implications for the Coronavirus Pandemic
por: Williams, Austin D., et al.
Publicado: (2021)

Quantitative, in situ analysis of mRNAs and proteins with subcellular resolution
por: Kwon, Sunjong, et al.
Publicado: (2017)

Predictive factors for the presence of invasive components in patients diagnosed with ductal carcinoma in situ based on preoperative biopsy
por: Lee, Kwan Ho, et al.
Publicado: (2019)

Preoperational diagnosis and management of breast ductal carcinoma in situ arising within fibroadenoma: Two case reports
por: Wu, Jun, et al.
Publicado: (2022)

Ductal carcinoma in situ (DCIS)
por: Holland, R
Publicado: (2002)

Ductal Carcinoma In Situ of the Breast
por: Lee, Richard J., et al.
Publicado: (2012)

Breast Ductal Carcinoma In Situ
por: Sacchini, Virgilio, et al.
Publicado: (2012)

Tamoxifen may prevent both ER+ and ER- breast cancers and select for ER- carcinogenesis: an alternative hypothesis
por: Esserman, Laura J, et al.
Publicado: (2005)

Correlation between imaging and pathology in ductal carcinoma in situ of the breast
por: de Roos, Marnix AJ, et al.
Publicado: (2004)

Growth Dynamics of Ductal Carcinoma in Situ Recapitulate Normal Breast Development
por: Ryser, Marc D., et al.
Publicado: (2023)

Different distribution of breast ductal carcinoma in situ, ductal carcinoma in situ with microinvasion, and invasion breast cancer
por: Wei, Zhang, et al.
Publicado: (2012)

Prediction of Sentinel Lymph Node Metastasis in Breast Ductal Carcinoma In Situ Diagnosed by Preoperative Core Needle Biopsy
por: Zhang, Kai, et al.
Publicado: (2020)

Does the Cytogenetic Analysis Using Fluorescence In Situ Hybridization Improve the Preoperative Diagnostic Accuracy of Pancreatic Ductal Adenocarcinoma?
por: Kim, Dong Uk
Publicado: (2020)

Pathological underestimation and biomarkers concordance rates in breast cancer patients diagnosed with ductal carcinoma in situ at preoperative biopsy
por: Zhou, Hemei, et al.
Publicado: (2022)

Preoperative ultrasound radiomics analysis for expression of multiple molecular biomarkers in mass type of breast ductal carcinoma in situ
por: Wu, Linyong, et al.
Publicado: (2021)

Imaging of Noncalcified Ductal Carcinoma In Situ
por: Bragg, Ashley, et al.
Publicado: (2021)

Endoplasmic Reticulum (ER) Stress and Endocrine Disorders
por: Ariyasu, Daisuke, et al.
Publicado: (2017)

Genomic differences between pure ductal carcinoma in situ and synchronous ductal carcinoma in situ with invasive breast cancer
por: Kim, Shinn Young, et al.
Publicado: (2015)

Comparison of breast ductal carcinoma in situ and ductal carcinoma in situ with microinvasion, and analysis of axillary lymph node metastasis
por: Zhang, Geng, et al.
Publicado: (2020)

Adenomyoepithelioma with Ductal Carcinoma In Situ: A Case Report and Review of the Literature
por: Warrier, Sanjay, et al.
Publicado: (2013)

The breast pre-cancer atlas illustrates the molecular and micro-environmental diversity of ductal carcinoma in situ
por: Nachmanson, Daniela, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b05p1f0s0dda1bd1s6c9on352p